ARTICLE | Clinical News
Olesoxime: Completed Phase Ib enrollment
August 19, 2013 7:00 AM UTC
Trophos completed enrollment of 44 patients with stable RRMS receiving interferon (IFN) beta in the double-blind, placebo-controlled, French Phase Ib Translate MS-Repair trial evaluating 495 mg oral o...